- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Radiology Trainees 95.9 Percent Right
Radiology trainees incorrectly interpreted pediatric neuroimaging scans 4.1 percent of the time, with a tiny fraction - 0.17 percent - of all readings erring in ways “major and potentially life-threatening,” according to a new study published in the American Journal of Neuroradiology.
Radiology trainees incorrectly interpreted pediatric neuroimaging scans 4.1 percent of the time, with a tiny fraction - 0.17 percent - of all readings erring in ways “major and potentially life-threatening,” according to a new study published in the American Journal of Neuroradiology.
Lead author James Leach, MD, and colleagues at the Cincinnati Children’s Hospital Medical Center considered 3,496 trainee-dictated examination reports. They found 143 errors, amounting to a discrepancy rate of 4.1 percent. Most discrepancies - 131, or 92 percent - occurred on CT examinations.
Most of these were minor, with no impact on clinical management (97, or 68 percent), or resulted simply in clinical reassessment or imaging follow-up (43, or 30 percent). Thirty-seven were overcalls. But six were major and potentially life-threatening.
The most common misinterpretations were related to fractures (28) and intracerebral hemorrhage (23). CT examinations of the face, orbits, and neck had the highest discrepancy rate (9.4 percent). Third- and fourth-year residents had a larger discrepancy rate than fellows. The authors said such detailed analysis of the types of misinterpretations can be used to inform proactive trainee education.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
